StealthBT
Edit

StealthBT

http://www.stealthbt.com/
Last activity: 29.02.2024
Categories: BioTechDevelopment
Stealth BioTherapeutics is a privately held clinical-stage biotechnology company focused on the development of therapeutics for diseases involving mitochondrial dysfunction.
Website visits
28.2K /mo.
Mentions
24
Location: United States, Massachusetts, Needham
Employees: 51-200
Founded date: 2007

Investors 2

Mentions in press and media 24

DateTitleDescriptionSource
12.02.2022Stealth BioTherapeutics Receives Nasdaq Notification Regardi...BOSTON, Feb. 11, 2022 /PRNewswire/ -- Stealth BioTherapeutics Corp (Nasdaq:MITO), a clinical-stage b...marketscre...
08.02.2022Stealth BioTherapeutics Announces Oral Presentation of New D...BOSTON, Feb. 8, 2022 /PRNewswire/ -- Stealth BioTherapeutics Corp (Nasdaq: MITO), a clinical-stage b...marketscre...
20.10.2021Stealth BioTherapeutics : Receives Refusal to File Letter fr...BOSTON, Oct. 20, 2021 /PRNewswire/ -- Stealth BioTherapeutics Corp (Nasdaq: MITO), a clinical-stage ...marketscre...
14.09.2021Aduhelm backlash threatens to reverse progress in FDA’s revi...The FDA’s approval of Aduhelm to treat Alzheimer’s disease has unleashed criticism about the decisio...statnews.c...
25.08.2021BSF Statement on Stealth BioTherapeutics’ U.S. FDA Submissio...BOSTON (PRWEB) August 25, 2021 The Barth Syndrome Foundation (BSF) expresses immense gratitude to St...prweb.com/...
01.06.2021STEALTH BIOTHERAPEUTICS CORP Stealth BioTherapeutics : Rece...BOSTON, June 1, 2021 /PRNewswire/ -- Stealth BioTherapeutics Corp (Nasdaq: MITO), a clinical-stage b...marketscre...
01.06.2021Stealth BioTherapeutics Receives Orphan Drug Designation fro...prnewswire...
18.05.2021STEALTH BIOTHERAPEUTICS CORP Stealth BioTherapeutics : Anno...BOSTON, May 17, 2021 /PRNewswire/ -- Stealth BioTherapeutics Corp (Nasdaq: MITO), a clinical-stage b...marketscre...
17.05.2021Stealth BioTherapeutics Announces Poster Presentation at Ame...prnewswire...
17.05.2021Stealth BioTherapeutics Announces Additional Development Fin...prnewswire...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In